Patents by Inventor Harsh Shailesh Shah

Harsh Shailesh Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RXR agonist salt form, polymorphs thereof, and uses thereof
    Patent number: 11919848
    Abstract: Provided herein are salt and solid forms of (2E,4E)-3-methyl-5-((1S,2S)-2-methyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)penta-2,4-dienoic acid, including a Tris salt form of (2E,4E)-3-methyl-5-((1S,2S)-2-methyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)penta-2,4-dienoic acid, and polymorphs thereof, methods of preparing the compounds, and their uses.
    Type: Grant
    Filed: March 14, 2023
    Date of Patent: March 5, 2024
    Assignee: Io Therapeutics, Inc.
    Inventors: Vidyasagar Vuligonda, Martin E. Sanders, Shanming Kuang, Harsh Shailesh Shah
  • RXR AGONIST SALT FORM, POLYMORPHS THEREOF, AND USES THEREOF
    Publication number: 20230295069
    Abstract: Provided herein are salt and solid forms of (2E,4E)-3-methyl-5-((1S,2S)-2-methyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)penta-2,4-dienoic acid, including a Tris salt form of (2E,4E)-3-methyl-5-((1S,2S)-2-methyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)penta-2,4-dienoic acid, and polymorphs thereof, methods of preparing the compounds, and their uses.
    Type: Application
    Filed: March 14, 2023
    Publication date: September 21, 2023
    Inventors: Vidyasagar Vuligonda, Martin E. Sanders, Shanming Kuang, Harsh Shailesh Shah